Onxeo SA (Germany) Market Value
| C4X Stock | EUR 0.07 0 4.20% |
| Symbol | Onxeo |
Onxeo SA 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Onxeo SA's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Onxeo SA.
| 11/03/2024 |
| 12/03/2024 |
If you would invest 0.00 in Onxeo SA on November 3, 2024 and sell it all today you would earn a total of 0.00 from holding Onxeo SA or generate 0.0% return on investment in Onxeo SA over 30 days. Onxeo SA is related to or competes with Mercedes-Benz Group, Moderna, BioNTech, Superior Plus, NMI Holdings, Origin Agritech, and SIVERS SEMICONDUCTORS. Onxeo SA, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions wor... More
Onxeo SA Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Onxeo SA's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Onxeo SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.32 | |||
| Information Ratio | 0.0272 | |||
| Maximum Drawdown | 65.03 | |||
| Value At Risk | (12.59) | |||
| Potential Upside | 14.8 |
Onxeo SA Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Onxeo SA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Onxeo SA's standard deviation. In reality, there are many statistical measures that can use Onxeo SA historical prices to predict the future Onxeo SA's volatility.| Risk Adjusted Performance | 0.0393 | |||
| Jensen Alpha | 0.6548 | |||
| Total Risk Alpha | (1.13) | |||
| Sortino Ratio | 0.0297 | |||
| Treynor Ratio | (0.17) |
Onxeo SA Backtested Returns
Onxeo SA appears to be out of control, given 3 months investment horizon. Onxeo SA maintains Sharpe Ratio (i.e., Efficiency) of 0.0372, which implies the firm had a 0.0372% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Onxeo SA, which you can use to evaluate the volatility of the company. Please evaluate Onxeo SA's Semi Deviation of 7.91, risk adjusted performance of 0.0393, and Coefficient Of Variation of 2538.43 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Onxeo SA holds a performance score of 2. The company holds a Beta of -2.3, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Onxeo SA are expected to decrease by larger amounts. On the other hand, during market turmoil, Onxeo SA is expected to outperform it. Please check Onxeo SA's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to make a quick decision on whether Onxeo SA's historical price patterns will revert.
Auto-correlation | 0.48 |
Average predictability
Onxeo SA has average predictability. Overlapping area represents the amount of predictability between Onxeo SA time series from 3rd of November 2024 to 18th of November 2024 and 18th of November 2024 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Onxeo SA price movement. The serial correlation of 0.48 indicates that about 48.0% of current Onxeo SA price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.48 | |
| Spearman Rank Test | 0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Onxeo SA lagged returns against current returns
Autocorrelation, which is Onxeo SA stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Onxeo SA's stock expected returns. We can calculate the autocorrelation of Onxeo SA returns to help us make a trade decision. For example, suppose you find that Onxeo SA has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Onxeo SA regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Onxeo SA stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Onxeo SA stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Onxeo SA stock over time.
Current vs Lagged Prices |
| Timeline |
Onxeo SA Lagged Returns
When evaluating Onxeo SA's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Onxeo SA stock have on its future price. Onxeo SA autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Onxeo SA autocorrelation shows the relationship between Onxeo SA stock current value and its past values and can show if there is a momentum factor associated with investing in Onxeo SA.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Onxeo Stock
Onxeo SA financial ratios help investors to determine whether Onxeo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Onxeo with respect to the benefits of owning Onxeo SA security.